Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04105309 · ClinicalTrials.gov registry record · Phase 2

Implementation Intentions for Weight Loss and Dietary Change in College Students With Overweight and Obesity

A Phase 2 study, sponsored by Washington University School of Medicine.

Completed
Registry status
Phase 2
Development phase
95
Enrollment target

NCT04105309 is a Phase 2 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 95 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04105309, a Phase 2 study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
Phase 2
Development phase
95 participants
Enrollment target

Study Summary

One in three college students have overweight or obesity and are in need of brief and simple weight loss interventions that complement their unstructured lifestyles. Implementation intentions, a strategy that connects a goal-aligned behavior to a cue, facilitate goal-attainment for a wide variety of health-behaviors, but have not been tested as a stand-alone treatment for weight loss in students. College students with overweight or obesity (N = 95) were randomized to one of three conditions: an implementation intention group (IMP), an enhanced implementation intention group (IMP+) that included text message reminders and fluency training (i.e., training for speed and accuracy), and a control goal intention group (GOL) for four weeks. Participants completed anthropometric and self-report assessments pre- and post-treatment as well as experience-sampling assessments during the study to assess how implementation intentions contribute more directly to behavior change

Interventions

  • BEHAVIORAL Text Messages
  • BEHAVIORAL Implementation Intentions
  • BEHAVIORAL Fluency Training
  • BEHAVIORAL Goal Intentions

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2017-06-01
Est. Completion 2018-06-30
Phase Phase 2

What the Registry Record Tells You About NCT04105309

The ClinicalTrials.gov registry entry for NCT04105309 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Text Messages is the first listed.

NCT04105309 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04105309 about?

NCT04105309 is a clinical study titled "Implementation Intentions for Weight Loss and Dietary Change in College Students With Overweight and Obesity". One in three college students have overweight or obesity and are in need of brief and simple weight loss interventions that complement their unstructured lifestyles. Implementation intentions, a strategy that connects a goal-aligned behavior to a cue, facilitate goal-attainment for a wide variety of...

What is the current status of trial NCT04105309?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 95 participants. The study started on 2017-06-01. Estimated completion is 2018-06-30.

What interventions are being tested in trial NCT04105309?

The interventions under investigation include: Text Messages (BEHAVIORAL), Implementation Intentions (BEHAVIORAL), Fluency Training (BEHAVIORAL), Goal Intentions (BEHAVIORAL).

Who is sponsoring clinical trial NCT04105309?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.